A molecular test, based on gene expression, for prediction of long-term effect of endocrine treatment in estrogen receptor positive (ER+), high-risk, breast cancer patients thereby allowing individualized adjuvant treatment of these patients

Maria Bibi Lyng (Inventor), Henrik Ditzel (Inventor), Anne Vibeke Lænkholm (Inventor)

Research output: Patent

Translated title of the contributionMolekylær test, baseret på genekspression, til prædiktion af langtids-effekt af endokrin behandling af østrogenreceptor-positive, høj-risiko, brystkræft patienter, hvorved individualiseret adjuverende behandling af disse patiener muliggøres
Original languageEnglish
IPCP1177DK00
Patent numberP1177US00
Filing date27/01/2011
Country/TerritoryDenmark
Publication statusPublished - 21. Feb 2011

Cite this